For best safety and efficacy outcomes, trials in psoriatic arthritis should use active comparators and stricter remission criteria, with outcome measures that are important to patients.
PsA Trial Design Can Improve Patient Safety, Outcomes
The Rheumatologist | Geplaatst op 16.06.2022 04:40